Quantitative MRI and Vertebral Bone Quality Scoring for Fragility Fracture Risk Prediction Beyond Density

Bone mineral density alone does not fully capture fracture risk; bone quality, microarchitecture, and marrow composition are important complementary dimensions. Relative to a DEXA-BMD-centered assessment framework, this work emphasizes that many fractures occur in patients without osteoporosis by DEXA criteria, bringing bone-quality-related metrics into the scope of risk prediction. A review-level argument based on a directional synthesis of existing imaging and biomarker research; no specific cohort sizes or effect sizes are given in the text.

Quantitative MRI parameters can non-invasively reflect bone-quality-related features and correlate with trabecular deterioration and cortical porosity. It systematically links quantitative MRI techniques such as T1ρ, T2 mapping, proton density fat fraction, and diffusion-weighted imaging to collagen integrity, proteoglycan content, water distribution, and marrow adiposity, expanding information beyond bone quantity alone. Presented in the text as correlations ("correlate with trabecular deterioration and cortical porosity"), without specific correlation coefficients or sample sizes.

VBQ scoring can serve as a practical surrogate for bone quality, and modified VBQ improves accuracy by minimizing posterior vertebral artefacts. VBQ is derived from routine T1-weighted MRI by quantifying vertebral marrow signal intensity relative to cerebrospinal fluid; modified VBQ shows stronger correlation with DEXA T scores and trabecular microarchitecture, improving clinical accessibility. The text reports that modified VBQ correlates more strongly with DEXA T scores and trabecular microarchitecture, but gives no specific statistical values.

VBQ predicts vertebral fragility fractures independently of BMD, with sensitivity exceeding 90% and discriminatory ability comparable to the fracture risk assessment tool and trabecular bone score. It positions VBQ's predictive value as information independent of BMD and reports performance comparable to established mainstream risk assessment tools. The text explicitly states "sensitivity exceeding 90%" and comparable discriminatory ability to FRAX and trabecular bone score, but does not list specific study counts, sample sizes, or confidence intervals.

This is a review-level synthesis intended for readers who want to understand new directions in fracture risk prediction beyond bone density, especially clinical and research settings focused on imaging biomarkers and opportunistic screening. Its conclusions point toward integrating VBQ/modified VBQ and quantitative MRI parameters into routine MRI workflows and using artificial intelligence to build predictive models, thereby supporting radiation-free risk stratification.

Readers may still wonder about: the comparability of quantitative MRI parameters (T1ρ, T2 mapping, proton density fat fraction, diffusion-weighted imaging) across scanners and sequences; the thresholds and standardization of VBQ and modified VBQ; the populations and fracture types underlying the sensitivity exceeding 90%; and how AI-integrated models perform in real screening workflows. Because the current text is a review-level summary without figures or specific statistical details, these questions remain open within its scope.